1991
DOI: 10.1016/0268-960x(91)90016-6
|View full text |Cite
|
Sign up to set email alerts
|

Human plasma fractionation and the impact of new technologies on the use and quality of plasma-derived products

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

1998
1998
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 35 publications
0
8
0
Order By: Relevance
“…Centrifugation separates blood components on the basis of their density gradients. Platelets are the lightest components, followed by WBCs, and RBCs are heaviest [26]. Therefore, RCF and time must be appropriate to obtain optimal separation of blood components.…”
Section: Discussionmentioning
confidence: 99%
“…Centrifugation separates blood components on the basis of their density gradients. Platelets are the lightest components, followed by WBCs, and RBCs are heaviest [26]. Therefore, RCF and time must be appropriate to obtain optimal separation of blood components.…”
Section: Discussionmentioning
confidence: 99%
“…Blood plasma is a complex media, which contains a different type of proteins, enzymes, cofactors, inorganic ions, etc . Some of the blood plasma components can interact with quantum dots or tetrapyrrole compounds .…”
Section: Introductionmentioning
confidence: 99%
“…Human plasma is a valuable raw material that produces functional proteins used in the therapy of coagulation, haematological and immunological disorders [ 1 , 2 , 3 , 4 ]. The quality of this starting material and the final products derived from it depends on two main factors: the blood or plasma of donors [ 5 ], and plasma preparation method [ 3 , 6 , 7 , 8 , 9 ].…”
Section: Introductionmentioning
confidence: 99%